Clinical Trial Update: Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study comparing Modified FOLFOX with or without nivolumab and ipilimumab versus FLOT with nivolumab in previously untreated advanced or metastatic gas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• DOCETAXEL (DOCETAXEL)
• Ipilimumab (Yervoy) (ipilimumab)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• nivolumab (Opdivo) (nivolumab)

Snippet

Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Conditions: Adenocarcinoma of the Stomach, GastroEsophageal Cancer | Phase 2 | Status: COMPLETED